D-0925-2023 Class II Ongoing
FDA drug recall D-0925-2023 was initiated by Ascend Laboratories, LLC on Jul 11, 2023 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is ongoing. Affected quantity: 2652 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 26, 2023
- Initiation Date
- Jul 11, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2652 bottles
Product description
Fingolimod Capsules, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-476-30.
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide in the USA
Code information
Lot 22122841, Exp August 2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0925-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026